Cancer-Fighting virus teams up with immunotherapy in new trial
Disease control
Recruiting now
This early-stage trial is testing a new combination treatment for patients with advanced neuroendocrine tumors that have progressed after standard therapy. Researchers are combining an experimental virus designed to attack cancer cells (SVV-001) with two established immunotherapy…
Phase: PHASE1 • Sponsor: Peter Hosein, MD • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC